TABLE 1.
Clinical features associated with patients who had typhoid relapses and who provided S. enterica serovar Typhi samples for the study
| Strain designationa | Treatment | Duration of treatment (days) | Complication | Fever clearance time (h) |
|---|---|---|---|---|
| RR1-A | Ceftriaxone | 3 | None | 162 |
| RR1-R | Ofloxacin | 5 | None | 100 |
| RR2-A | Ofloxacin | 3 | None | 90 |
| RR2-R | Ofloxacin | 7 | None | Unknown |
| RR3-A | Ofloxacin | 3 | Gastrointestinal bleeding | 114 |
| RR3-R | Ofloxacin | 10 | None | 114 |
| RR4-A | Ofloxacin | 2 | None | 72 |
| RR4-R | Ofloxacin | 7 | None | 72 |
| RR5-A | Cefixime | 7 | None | 180 |
| RR5-R | Ofloxacin | 20 | None | 150 |
| RR6-A | Ofloxacin | 7 | None | Unknown |
| RR6-R | Ofloxacin | 20 | Severe | 168 |
| RR7-A | Ofloxacin | 7 | None | 180 |
| RR7-R | Ofloxacin | 6 | None | 96 |
| RR8-A | Ofloxacin | 8 | None | 140 |
| RR8-R | Ofloxacin | 3 | None | 68 |
| RR9-A | Ofloxacin | 24 | None | Unknown |
| RR9-R | Ofloxacin | 5 | None | 60 |
| RR10-A | Ofloxacin | 7 | None | 112 |
| RR10-R | Ofloxacin | 5 | None | 56 |
a
A, strain from acute phase sample; R, strain from relapse-phase sample.